Nymox (NYMX) Issues Positive Results from LT Prostate Enlargement Study
Tweet Send to a Friend
Nymox Pharmaceutical Corporation (Nasdaq: NYMX) lead drug fexapotide which has been in development for over a decade and which has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE